Exact Mass: 663.4921214

Exact Mass Matches: 663.4921214

Found 174 metabolites which its exact mass value is equals to given mass value 663.4921214, within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error 0.001 dalton.

PE(14:0/16:0)

(2-aminoethoxy)[(2R)-2-(hexadecanoyloxy)-3-(tetradecanoyloxy)propoxy]phosphinic acid

C35H70NO8P (663.483879)


PE(14:0/16:0) is a phosphatidylethanolamine (PE or GPEtn). It is a glycerophospholipid in which a phosphorylethanolamine moiety occupies a glycerol substitution site. As is the case with diacylglycerols, glycerophosphoethanolamines can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. PE(14:0/16:0), in particular, consists of one chain of myristic acid at the C-1 position and one chain of palmitic acid at the C-2 position. The myristic acid moiety is derived from nutmeg and butter, while the palmitic acid moiety is derived from fish oils, milk fats, vegetable oils and animal fats. Phospholipids, are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling.While most phospholipids have a saturated fatty acid on C-1 and an unsaturated fatty acid on C-2 of the glycerol backbone, the fatty acid distribution at the C-1 and C-2 positions of glycerol within phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. PEs are neutral zwitterions at physiological pH. They mostly have palmitic or stearic acid on carbon 1 and a long chain unsaturated fatty acid (e.g. 18:2, 20:4 and 22:6) on carbon 2. PE synthesis can occur via two pathways. The first requires that ethanolamine be activated by phosphorylation and then coupled to CDP. The ethanolamine is then transferred from CDP-ethanolamine to phosphatidic acid to yield PE. The second involves the decarboxylation of PS. PE(14:0/16:0) is a phosphatidylethanolamine. It is a glycerophospholipid in which a phosphorylethanolamine moiety occupies a glycerol substitution site. As is the case with diacylglycerols, glycerophosphoethanolamines can have many different combinations of fatty acids of varying lengths and saturation attached to the C-1 and C-2 atoms. PE(14:0/16:0), in particular, consists of one tetradecanoyl chain to the C-1 atom, and one hexadecanoyl to the C-2 atom. While most phospholipids have a saturated fatty acid on C-1 and an unsaturated fatty acid on C-2 of the glycerol backbone, the fatty acid distribution at the C-1 and C-2 positions of glycerol within phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. PEs are neutral zwitterions at physiological pH. They mostly have palmitic or stearic acid on carbon 1 and a long chain unsaturated fatty acid (e.g. 18:2, 20:4 and 22:6) on carbon 2. PE synthesis can occur via two pathways. The first requires that ethanolamine be activated by phosphorylation and then coupled to CDP. The ethanolamine is then transferred from CDP-ethanolamine to phosphatidic acid to yield PE. The second involves the decarboxylation of PS.

   

PE(15:0/15:0)

(2-aminoethoxy)[(2R)-2,3-bis(pentadecanoyloxy)propoxy]phosphinic acid

C35H70NO8P (663.483879)


PE(15:0/15:0) is a phosphatidylethanolamine (PE or GPEtn). It is a glycerophospholipid in which a phosphorylethanolamine moiety occupies a glycerol substitution site. As is the case with diacylglycerols, glycerophosphoethanolamines can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. PE(15:0/15:0), in particular, consists of two chains of pentadecanoic acid at the C-1 and C-2 positions. The pentadecanoic acid moieties are derived from dairy products and milk fat. Phospholipids, are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling.While most phospholipids have a saturated fatty acid on C-1 and an unsaturated fatty acid on C-2 of the glycerol backbone, the fatty acid distribution at the C-1 and C-2 positions of glycerol within phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. PEs are neutral zwitterions at physiological pH. They mostly have palmitic or stearic acid on carbon 1 and a long chain unsaturated fatty acid (e.g. 18:2, 20:4 and 22:6) on carbon 2. PE synthesis can occur via two pathways. The first requires that ethanolamine be activated by phosphorylation and then coupled to CDP. The ethanolamine is then transferred from CDP-ethanolamine to phosphatidic acid to yield PE. The second involves the decarboxylation of PS. PE(15:0/15:0) is a phosphatidylethanolamine. It is a glycerophospholipid in which a phosphorylethanolamine moiety occupies a glycerol substitution site. As is the case with diacylglycerols, glycerophosphoethanolamines can have many different combinations of fatty acids of varying lengths and saturation attached to the C-1 and C-2 positions. PE(15:0/15:0), in particular, consists of two pentadecanoyl chains at positions C-1 and C-2. While most phospholipids have a saturated fatty acid on C-1 and an unsaturated fatty acid on C-2 of the glycerol backbone, the fatty acid distribution at the C-1 and C-2 positions of glycerol within phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. PEs are neutral zwitterions at physiological pH. They mostly have palmitic or stearic acid on carbon 1 and a long chain unsaturated fatty acid (e.g. 18:2, 20:4 and 22:6) on carbon 2. PE synthesis can occur via two pathways. The first requires that ethanolamine be activated by phosphorylation and then coupled to CDP. The ethanolamine is then transferred from CDP-ethanolamine to phosphatidic acid to yield PE. The second involves the decarboxylation of PS.

   

PE(16:0/14:0)

(2-aminoethoxy)[(2R)-3-(hexadecanoyloxy)-2-(tetradecanoyloxy)propoxy]phosphinic acid

C35H70NO8P (663.483879)


PE(16:0/14:0) is a phosphatidylethanolamine (PE or GPEtn). It is a glycerophospholipid in which a phosphorylethanolamine moiety occupies a glycerol substitution site. As is the case with diacylglycerols, glycerophosphoethanolamines can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. PE(16:0/14:0), in particular, consists of one chain of palmitic acid at the C-1 position and one chain of myristic acid at the C-2 position. The palmitic acid moiety is derived from fish oils, milk fats, vegetable oils and animal fats, while the myristic acid moiety is derived from nutmeg and butter. Phospholipids, are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling.While most phospholipids have a saturated fatty acid on C-1 and an unsaturated fatty acid on C-2 of the glycerol backbone, the fatty acid distribution at the C-1 and C-2 positions of glycerol within phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. PEs are neutral zwitterions at physiological pH. They mostly have palmitic or stearic acid on carbon 1 and a long chain unsaturated fatty acid (e.g. 18:2, 20:4 and 22:6) on carbon 2. PE synthesis can occur via two pathways. The first requires that ethanolamine be activated by phosphorylation and then coupled to CDP. The ethanolamine is then transferred from CDP-ethanolamine to phosphatidic acid to yield PE. The second involves the decarboxylation of PS. PE(16:0/14:0) is a phosphatidylethanolamine. It is a glycerophospholipid in which a phosphorylethanolamine moiety occupies a glycerol substitution site. As is the case with diacylglycerols, glycerophosphoethanolamines can have many different combinations of fatty acids of varying lengths and saturation attached to the C-1 and C-2 atoms. PE(16:0/14:0), in particular, consists of one hexadecanoyl chain to the C-1 atom, and one tetradecanoyl to the C-2 atom. While most phospholipids have a saturated fatty acid on C-1 and an unsaturated fatty acid on C-2 of the glycerol backbone, the fatty acid distribution at the C-1 and C-2 positions of glycerol within phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. PEs are neutral zwitterions at physiological pH. They mostly have palmitic or stearic acid on carbon 1 and a long chain unsaturated fatty acid (e.g. 18:2, 20:4 and 22:6) on carbon 2. PE synthesis can occur via two pathways. The first requires that ethanolamine be activated by phosphorylation and then coupled to CDP. The ethanolamine is then transferred from CDP-ethanolamine to phosphatidic acid to yield PE. The second involves the decarboxylation of PS.

   

PE-NMe(14:0/15:0)

[2-(methylamino)ethoxy][2-(pentadecanoyloxy)-3-(tetradecanoyloxy)propoxy]phosphinic acid

C35H70NO8P (663.483879)


PE-NMe(14:0/15:0) is a monomethylphosphatidylethanolamine. It is a glycerophospholipid, and is formed by sequential methylation of phosphatidylethanolamine as part of a mechanism for biosynthesis of phosphatidylcholine. Monomethylphosphatidylethanolamines are usually found at trace levels in animal or plant tissues. They can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. PE-NMe(14:0/15:0), in particular, consists of one tetradecanoyl chain to the C-1 atom, and one pentadecanoyl to the C-2 atom. Fatty acids containing 16, 18 and 20 carbons are the most common. Phospholipids, are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling.

   

PE-NMe(15:0/14:0)

[2-(methylamino)ethoxy][3-(pentadecanoyloxy)-2-(tetradecanoyloxy)propoxy]phosphinic acid

C35H70NO8P (663.483879)


PE-NMe(15:0/14:0) is a monomethylphosphatidylethanolamine. It is a glycerophospholipid, and it is formed by sequential methylation of phosphatidylethanolamine as part of a mechanism for biosynthesis of phosphatidylcholine. Monomethylphosphatidylethanolamines are usually found at trace levels in animal or plant tissues. They can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. PE-NMe(15:0/14:0), in particular, consists of one chain of pentadecanoic acid at the C-1 position and one chain of myristic acid at the C-2 position. Fatty acids containing 16, 18 and 20 carbons are the most common. Phospholipids are ubiquitous in nature. They are key components of the cell lipid bilayer and are involved in metabolism and signaling.

   

PE-NMe2(14:0/14:0)

[2,3-bis(tetradecanoyloxy)propoxy][2-(dimethylamino)ethoxy]phosphinic acid

C35H70NO8P (663.483879)


PE-NMe2(14:0/14:0) is a dimethylphosphatidylethanolamine. It is a glycerophospholipid, and is formed by sequential methylation of phosphatidylethanolamine as part of a mechanism for biosynthesis of phosphatidylcholine. Dimethylphosphatidylethanolamines are usually found at trace levels in animal or plant tissues. They can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions.PE-NMe2(14:0/14:0), in particular, consists of two tetradecanoyl chain at positions C-1 and C2. Fatty acids containing 16, 18 and 20 carbons are the most common. Phospholipids, are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling.

   

Phosphatidylethanolamine (15:0/15:0) Abbr: Di-(15)PE

Phosphatidylethanolamine (15:0/15:0) Abbr: Di-(15)PE

C35H70NO8P (663.483879)


   

phosphatidylethanolamine (14:0/16:0)

phosphatidylethanolamine (14:0/16:0)

C35H70NO8P (663.483879)


   

PC(13:0/14:0)[U]

3,5,8-Trioxa-4-phosphadocosan-1-aminium, 4-hydroxy-N,N,N-trimethyl-9-oxo-7-[[(1-oxotridecyl)oxy]methyl]-, inner salt, 4-oxide

C35H70NO8P (663.483879)


   

PC(14:0/13:0)[U]

3,5,9-Trioxa-4-phosphatricosan-1-aminium, 4-hydroxy-N,N,N-trimethyl-10-oxo-7-[(1-oxotridecyl)oxy]-, inner salt, 4-oxide

C35H70NO8P (663.483879)


   

PC(15:0/12:0)[U]

3,5,9-Trioxa-4-phosphatetracosan-1-aminium, 4-hydroxy-N,N,N-trimethyl-10-oxo-7-[(1-oxododecyl)oxy]-, inner salt, 4-oxide

C35H70NO8P (663.483879)


   

PC(16:0/11:0)[U]

3,5,9-Trioxa-4-phosphapentacosan-1-aminium, 4-hydroxy-N,N,N-trimethyl-10-oxo-7-[(1-oxoundecyl)oxy]-, inner salt, 4-oxide

C35H70NO8P (663.483879)


   

PC(17:0/10:0)

3,5,9-Trioxa-4-phosphahexacosan-1-aminium, 4-hydroxy-N,N,N-trimethyl-10-oxo-7-[(1-oxodecyl)oxy]-, inner salt, 4-oxide, (R)-

C35H70NO8P (663.483879)


   

PC(18:0/9:0)[U]

3,5,9-trioxa-4-phosphaheptacosan-1-aminium-, 4-hydroxy-N,N,N,-trimethyl-10-oxo-7-[1(1-oxononyl)oxy]-, inner salt, 4-oxide

C35H70NO8P (663.483879)


   

PC(8:0/19:0)

3,5,8-Trioxa-4-phosphaheptacosan-1-aminium, 4-hydroxy-N,N,N-trimethyl-9-oxo-7-[[(1-oxooctyl)oxy]methyl]-, inner salt, 4-oxide, (R)-

C35H70NO8P (663.483879)


   

PC(9:0/18:0)

3,5,8-Trioxa-4-phosphahexacosan-1-aminium, 4-hydroxy-N,N,N-trimethyl-9-oxo-7-[[(1-oxononyl)oxy]methyl]-, inner salt, 4-oxide, (R)-

C35H70NO8P (663.483879)


   

PE(18:0/12:0)[U]

Octadecanoic acid, 3-[[(2-aminoethoxy)hydroxyphosphinyl]oxy]-2-[(1-oxododecyl)oxy]propyl ester

C35H70NO8P (663.483879)


   

PE(15:0/15:0)

Pentadecanoic acid, 1-[[[(2-aminoethoxy)hydroxyphosphinyl]oxy]methyl]-1,2-ethanediyl ester, (R)-

C35H70NO8P (663.483879)


   

PE(15:0/15:0)[U]

Pentadecanoic acid, 1-[[[(2-aminoethoxy)hydroxyphosphinyl]oxy]methyl]-1,2-ethanediyl ester

C35H70NO8P (663.483879)


   

PE(12:0/18:0)[U]

1-dodecanoyl-2-octadecanoyl-sn-glycero-3-phosphoethanolamine

C35H70NO8P (663.483879)


   

PE(11:0/19:0)[U]

1-undecanoyl-2-nonadecanoyl-sn-glycero-3-phosphoethanolamine

C35H70NO8P (663.483879)


   

PE(13:0/17:0)[U]

1-tridecanoyl-2-heptadecanoyl-sn-glycero-3-phosphoethanolamine

C35H70NO8P (663.483879)


   

PE(17:0/13:0)[U]

1-heptadecanoyl-2-tridecanoyl-sn-glycero-3-phosphoethanolamine

C35H70NO8P (663.483879)


   

PE(16:0/14:0)

Hexadecanoic acid, 3-[[(2-aminoethoxy)hydroxyphosphinyl]oxy]-2-[(1-oxotetradecyl)oxy]propyl ester, (R)- (9CI)

C35H70NO8P (663.483879)


   

PE(14:0/16:0)

Hexadecanoic acid, 1-[[[(2-aminoethoxy)hydroxyphosphinyl]oxy]methyl]-2-[(1-oxotetradecyl)oxy]ethyl ester, (R)- (9CI)

C35H70NO8P (663.483879)


   

GPEtnNMe2(14:0/14:0)

Tetradecanoic acid, 1-[[[[2-(dimethylamino)ethoxy]hydroxyphosphinyl]oxy]methyl]-1,2-ethanediyl ester, (R)-

C35H70NO8P (663.483879)


   

GPEtnNMe2(14:0/14:0)[U]

Tetradecanoic acid, 5-hydroxy-9-methyl-2-[(1-oxotetradecyl)oxy]-4,6-dioxa-9-aza-5-phosphadec-1-yl ester, P-oxide

C35H70NO8P (663.483879)


   

PC(12:0/15:0)

1-dodecanoyl-2-pentadecanoyl-glycero-3-phosphocholine

C35H70NO8P (663.483879)


   

PC(13:0/14:0)

1-tridecanoyl-2-tetradecanoyl-glycero-3-phosphocholine

C35H70NO8P (663.483879)


   

PC(14:0/13:0)

1-tetradecanoyl-2-tridecanoyl-glycero-3-phosphocholine

C35H70NO8P (663.483879)


   

PC(15:0/12:0)

1-pentadecanoyl-2-dodecanoyl-glycero-3-phosphocholine

C35H70NO8P (663.483879)


   

PE(18:0/12:0)

1-octadecanoyl-2-dodecanoyl-glycero-3-phosphoethanolamine

C35H70NO8P (663.483879)


   

PE(17:0/13:0)

1-heptadecanoyl-2-tridecanoyl-glycero-3-phosphoethanolamine

C35H70NO8P (663.483879)


   

PE(13:0/17:0)

1-tridecanoyl-2-heptadecanoyl-glycero-3-phosphoethanolamine

C35H70NO8P (663.483879)


   

PE(12:0/18:0)

1-dodecanoyl-2-octadecanoyl-glycero-3-phosphoethanolamine

C35H70NO8P (663.483879)


   

PC 27:0

1-undecanoyl-2-hexadecanoyl-sn-glycero-3-phosphocholine

C35H70NO8P (663.483879)


   

PE 30:0

Hexadecanoic acid, 1-[[[(2-aminoethoxy)hydroxyphosphinyl]oxy]methyl]-2-[(1-oxotetradecyl)oxy]ethyl ester, (R)- (9CI)

C35H70NO8P (663.483879)


   

PE-NMe2 28:0

Tetradecanoic acid, 1-[[[[2-(dimethylamino)ethoxy]hydroxyphosphinyl]oxy]methyl]-1,2-ethanediyl ester, (R)-

C35H70NO8P (663.483879)


   

[(2R)-2-hexadecanoyloxy-3-undecanoyloxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

[(2R)-2-hexadecanoyloxy-3-undecanoyloxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C35H70NO8P (663.483879)


   

1-octadecanoyl-2-nonanoyl-sn-glycero-3-phosphocholine

1-octadecanoyl-2-nonanoyl-sn-glycero-3-phosphocholine

C35H70NO8P (663.483879)


A phosphatidylcholine 27:0 in which the acyl groups at positions 1 and 2 are specified as octadecanoyl and nonanoyl respectively.

   

Dipentadecanoyophosphatidylethalamine

Dipentadecanoyophosphatidylethalamine

C35H70NO8P (663.483879)


   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   

HexCer 8:0;3O/21:0;(2OH)

HexCer 8:0;3O/21:0;(2OH)

C35H69NO10 (663.4921214)


   

HexCer 9:0;3O/20:0;(2OH)

HexCer 9:0;3O/20:0;(2OH)

C35H69NO10 (663.4921214)


   

HexCer 10:0;3O/19:0;(2OH)

HexCer 10:0;3O/19:0;(2OH)

C35H69NO10 (663.4921214)


   

HexCer 11:0;3O/18:0;(2OH)

HexCer 11:0;3O/18:0;(2OH)

C35H69NO10 (663.4921214)


   

HexCer 13:0;3O/16:0;(2OH)

HexCer 13:0;3O/16:0;(2OH)

C35H69NO10 (663.4921214)


   

HexCer 12:0;3O/17:0;(2OH)

HexCer 12:0;3O/17:0;(2OH)

C35H69NO10 (663.4921214)


   

3-hydroxy-2-[[(5Z,8Z,11Z,14Z,17Z)-icosa-5,8,11,14,17-pentaenoyl]amino]nonadecane-1-sulfonic acid

3-hydroxy-2-[[(5Z,8Z,11Z,14Z,17Z)-icosa-5,8,11,14,17-pentaenoyl]amino]nonadecane-1-sulfonic acid

C39H69NO5S (663.4896183999999)


   

(4E,8E,12E)-2-[[(9Z,12Z)-heptadeca-9,12-dienoyl]amino]-3-hydroxydocosa-4,8,12-triene-1-sulfonic acid

(4E,8E,12E)-2-[[(9Z,12Z)-heptadeca-9,12-dienoyl]amino]-3-hydroxydocosa-4,8,12-triene-1-sulfonic acid

C39H69NO5S (663.4896183999999)


   

(4E,8E,12E)-3-hydroxy-2-[[(13Z,16Z)-tetracosa-13,16-dienoyl]amino]pentadeca-4,8,12-triene-1-sulfonic acid

(4E,8E,12E)-3-hydroxy-2-[[(13Z,16Z)-tetracosa-13,16-dienoyl]amino]pentadeca-4,8,12-triene-1-sulfonic acid

C39H69NO5S (663.4896183999999)


   

(4E,8E,12E)-3-hydroxy-2-[[(9Z,12Z)-octadeca-9,12-dienoyl]amino]henicosa-4,8,12-triene-1-sulfonic acid

(4E,8E,12E)-3-hydroxy-2-[[(9Z,12Z)-octadeca-9,12-dienoyl]amino]henicosa-4,8,12-triene-1-sulfonic acid

C39H69NO5S (663.4896183999999)


   

(4E,8E)-2-[[(7Z,10Z,13Z)-hexadeca-7,10,13-trienoyl]amino]-3-hydroxytricosa-4,8-diene-1-sulfonic acid

(4E,8E)-2-[[(7Z,10Z,13Z)-hexadeca-7,10,13-trienoyl]amino]-3-hydroxytricosa-4,8-diene-1-sulfonic acid

C39H69NO5S (663.4896183999999)


   

(E)-3-hydroxy-2-[[(8Z,11Z,14Z,17Z)-icosa-8,11,14,17-tetraenoyl]amino]nonadec-4-ene-1-sulfonic acid

(E)-3-hydroxy-2-[[(8Z,11Z,14Z,17Z)-icosa-8,11,14,17-tetraenoyl]amino]nonadec-4-ene-1-sulfonic acid

C39H69NO5S (663.4896183999999)


   

(4E,8E,12E)-2-[[(9Z,12Z)-hexadeca-9,12-dienoyl]amino]-3-hydroxytricosa-4,8,12-triene-1-sulfonic acid

(4E,8E,12E)-2-[[(9Z,12Z)-hexadeca-9,12-dienoyl]amino]-3-hydroxytricosa-4,8,12-triene-1-sulfonic acid

C39H69NO5S (663.4896183999999)


   

(E)-3-hydroxy-2-[[(6Z,9Z,12Z,15Z)-octadeca-6,9,12,15-tetraenoyl]amino]henicos-4-ene-1-sulfonic acid

(E)-3-hydroxy-2-[[(6Z,9Z,12Z,15Z)-octadeca-6,9,12,15-tetraenoyl]amino]henicos-4-ene-1-sulfonic acid

C39H69NO5S (663.4896183999999)


   

(4E,8E,12E)-3-hydroxy-2-[[(11Z,14Z)-icosa-11,14-dienoyl]amino]nonadeca-4,8,12-triene-1-sulfonic acid

(4E,8E,12E)-3-hydroxy-2-[[(11Z,14Z)-icosa-11,14-dienoyl]amino]nonadeca-4,8,12-triene-1-sulfonic acid

C39H69NO5S (663.4896183999999)


   

(4E,8E,12E)-2-[[(11Z,14Z)-henicosa-11,14-dienoyl]amino]-3-hydroxyoctadeca-4,8,12-triene-1-sulfonic acid

(4E,8E,12E)-2-[[(11Z,14Z)-henicosa-11,14-dienoyl]amino]-3-hydroxyoctadeca-4,8,12-triene-1-sulfonic acid

C39H69NO5S (663.4896183999999)


   

(4E,8E)-3-hydroxy-2-[[(11Z,14Z,17Z)-icosa-11,14,17-trienoyl]amino]nonadeca-4,8-diene-1-sulfonic acid

(4E,8E)-3-hydroxy-2-[[(11Z,14Z,17Z)-icosa-11,14,17-trienoyl]amino]nonadeca-4,8-diene-1-sulfonic acid

C39H69NO5S (663.4896183999999)


   

(4E,8E)-3-hydroxy-2-[[(9Z,12Z,15Z)-octadeca-9,12,15-trienoyl]amino]henicosa-4,8-diene-1-sulfonic acid

(4E,8E)-3-hydroxy-2-[[(9Z,12Z,15Z)-octadeca-9,12,15-trienoyl]amino]henicosa-4,8-diene-1-sulfonic acid

C39H69NO5S (663.4896183999999)


   

(E)-2-[[(14Z,17Z,20Z,23Z)-hexacosa-14,17,20,23-tetraenoyl]amino]-3-hydroxytridec-4-ene-1-sulfonic acid

(E)-2-[[(14Z,17Z,20Z,23Z)-hexacosa-14,17,20,23-tetraenoyl]amino]-3-hydroxytridec-4-ene-1-sulfonic acid

C39H69NO5S (663.4896183999999)


   

(4E,8E)-3-hydroxy-2-[[(10Z,13Z,16Z)-tetracosa-10,13,16-trienoyl]amino]pentadeca-4,8-diene-1-sulfonic acid

(4E,8E)-3-hydroxy-2-[[(10Z,13Z,16Z)-tetracosa-10,13,16-trienoyl]amino]pentadeca-4,8-diene-1-sulfonic acid

C39H69NO5S (663.4896183999999)


   

(4E,8E)-2-[[(10Z,13Z,16Z)-docosa-10,13,16-trienoyl]amino]-3-hydroxyheptadeca-4,8-diene-1-sulfonic acid

(4E,8E)-2-[[(10Z,13Z,16Z)-docosa-10,13,16-trienoyl]amino]-3-hydroxyheptadeca-4,8-diene-1-sulfonic acid

C39H69NO5S (663.4896183999999)


   

3-hydroxy-2-[[(3Z,6Z,9Z,12Z,15Z)-octadeca-3,6,9,12,15-pentaenoyl]amino]henicosane-1-sulfonic acid

3-hydroxy-2-[[(3Z,6Z,9Z,12Z,15Z)-octadeca-3,6,9,12,15-pentaenoyl]amino]henicosane-1-sulfonic acid

C39H69NO5S (663.4896183999999)


   

2-[[(11Z,14Z,17Z,20Z,23Z)-hexacosa-11,14,17,20,23-pentaenoyl]amino]-3-hydroxytridecane-1-sulfonic acid

2-[[(11Z,14Z,17Z,20Z,23Z)-hexacosa-11,14,17,20,23-pentaenoyl]amino]-3-hydroxytridecane-1-sulfonic acid

C39H69NO5S (663.4896183999999)


   

(4E,8E,12E)-3-hydroxy-2-[[(9Z,12Z)-nonadeca-9,12-dienoyl]amino]icosa-4,8,12-triene-1-sulfonic acid

(4E,8E,12E)-3-hydroxy-2-[[(9Z,12Z)-nonadeca-9,12-dienoyl]amino]icosa-4,8,12-triene-1-sulfonic acid

C39H69NO5S (663.4896183999999)


   

(E)-2-[[(10Z,13Z,16Z,19Z)-docosa-10,13,16,19-tetraenoyl]amino]-3-hydroxyheptadec-4-ene-1-sulfonic acid

(E)-2-[[(10Z,13Z,16Z,19Z)-docosa-10,13,16,19-tetraenoyl]amino]-3-hydroxyheptadec-4-ene-1-sulfonic acid

C39H69NO5S (663.4896183999999)


   

2-[[(7Z,10Z,13Z,16Z,19Z)-docosa-7,10,13,16,19-pentaenoyl]amino]-3-hydroxyheptadecane-1-sulfonic acid

2-[[(7Z,10Z,13Z,16Z,19Z)-docosa-7,10,13,16,19-pentaenoyl]amino]-3-hydroxyheptadecane-1-sulfonic acid

C39H69NO5S (663.4896183999999)


   

(E)-3-hydroxy-2-[[(12Z,15Z,18Z,21Z)-tetracosa-12,15,18,21-tetraenoyl]amino]pentadec-4-ene-1-sulfonic acid

(E)-3-hydroxy-2-[[(12Z,15Z,18Z,21Z)-tetracosa-12,15,18,21-tetraenoyl]amino]pentadec-4-ene-1-sulfonic acid

C39H69NO5S (663.4896183999999)


   

(4E,8E)-2-[[(12Z,15Z,18Z)-hexacosa-12,15,18-trienoyl]amino]-3-hydroxytrideca-4,8-diene-1-sulfonic acid

(4E,8E)-2-[[(12Z,15Z,18Z)-hexacosa-12,15,18-trienoyl]amino]-3-hydroxytrideca-4,8-diene-1-sulfonic acid

C39H69NO5S (663.4896183999999)


   

(4E,8E,12E)-2-[[(13Z,16Z)-docosa-13,16-dienoyl]amino]-3-hydroxyheptadeca-4,8,12-triene-1-sulfonic acid

(4E,8E,12E)-2-[[(13Z,16Z)-docosa-13,16-dienoyl]amino]-3-hydroxyheptadeca-4,8,12-triene-1-sulfonic acid

C39H69NO5S (663.4896183999999)


   

(E)-2-[[(4Z,7Z,10Z,13Z)-hexadeca-4,7,10,13-tetraenoyl]amino]-3-hydroxytricos-4-ene-1-sulfonic acid

(E)-2-[[(4Z,7Z,10Z,13Z)-hexadeca-4,7,10,13-tetraenoyl]amino]-3-hydroxytricos-4-ene-1-sulfonic acid

C39H69NO5S (663.4896183999999)


   

3-hydroxy-2-[[(9Z,12Z,15Z,18Z,21Z)-tetracosa-9,12,15,18,21-pentaenoyl]amino]pentadecane-1-sulfonic acid

3-hydroxy-2-[[(9Z,12Z,15Z,18Z,21Z)-tetracosa-9,12,15,18,21-pentaenoyl]amino]pentadecane-1-sulfonic acid

C39H69NO5S (663.4896183999999)


   

2-[4-[3-[(4Z,7Z,10Z,13Z)-hexadeca-4,7,10,13-tetraenoyl]oxy-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl]pentanoylamino]acetic acid

2-[4-[3-[(4Z,7Z,10Z,13Z)-hexadeca-4,7,10,13-tetraenoyl]oxy-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl]pentanoylamino]acetic acid

C42H65NO5 (663.4862479999999)


   

HexCer 15:0;3O/14:0;(2OH)

HexCer 15:0;3O/14:0;(2OH)

C35H69NO10 (663.4921214)


   

HexCer 16:0;3O/13:0;(2OH)

HexCer 16:0;3O/13:0;(2OH)

C35H69NO10 (663.4921214)


   

HexCer 14:0;3O/15:0;(2OH)

HexCer 14:0;3O/15:0;(2OH)

C35H69NO10 (663.4921214)


   

HexCer 17:0;3O/12:0;(2OH)

HexCer 17:0;3O/12:0;(2OH)

C35H69NO10 (663.4921214)


   

[1-[2-Aminoethoxy(hydroxy)phosphoryl]oxy-3-nonanoyloxypropan-2-yl] henicosanoate

[1-[2-Aminoethoxy(hydroxy)phosphoryl]oxy-3-nonanoyloxypropan-2-yl] henicosanoate

C35H70NO8P (663.483879)


   

[1-[2-Aminoethoxy(hydroxy)phosphoryl]oxy-3-dodecanoyloxypropan-2-yl] octadecanoate

[1-[2-Aminoethoxy(hydroxy)phosphoryl]oxy-3-dodecanoyloxypropan-2-yl] octadecanoate

C35H70NO8P (663.483879)


   

[1-[2-Aminoethoxy(hydroxy)phosphoryl]oxy-3-undecanoyloxypropan-2-yl] nonadecanoate

[1-[2-Aminoethoxy(hydroxy)phosphoryl]oxy-3-undecanoyloxypropan-2-yl] nonadecanoate

C35H70NO8P (663.483879)


   

[1-[2-Aminoethoxy(hydroxy)phosphoryl]oxy-3-tridecanoyloxypropan-2-yl] heptadecanoate

[1-[2-Aminoethoxy(hydroxy)phosphoryl]oxy-3-tridecanoyloxypropan-2-yl] heptadecanoate

C35H70NO8P (663.483879)


   

[1-[2-Aminoethoxy(hydroxy)phosphoryl]oxy-3-tetradecanoyloxypropan-2-yl] hexadecanoate

[1-[2-Aminoethoxy(hydroxy)phosphoryl]oxy-3-tetradecanoyloxypropan-2-yl] hexadecanoate

C35H70NO8P (663.483879)


   

[1-[2-Aminoethoxy(hydroxy)phosphoryl]oxy-3-decanoyloxypropan-2-yl] icosanoate

[1-[2-Aminoethoxy(hydroxy)phosphoryl]oxy-3-decanoyloxypropan-2-yl] icosanoate

C35H70NO8P (663.483879)


   

(3-Decanoyloxy-2-heptadecanoyloxypropyl) 2-(trimethylazaniumyl)ethyl phosphate

(3-Decanoyloxy-2-heptadecanoyloxypropyl) 2-(trimethylazaniumyl)ethyl phosphate

C35H70NO8P (663.483879)


   

(2-Hexadecanoyloxy-3-undecanoyloxypropyl) 2-(trimethylazaniumyl)ethyl phosphate

(2-Hexadecanoyloxy-3-undecanoyloxypropyl) 2-(trimethylazaniumyl)ethyl phosphate

C35H70NO8P (663.483879)


   

(3-Dodecanoyloxy-2-pentadecanoyloxypropyl) 2-(trimethylazaniumyl)ethyl phosphate

(3-Dodecanoyloxy-2-pentadecanoyloxypropyl) 2-(trimethylazaniumyl)ethyl phosphate

C35H70NO8P (663.483879)


   

(2-Tetradecanoyloxy-3-tridecanoyloxypropyl) 2-(trimethylazaniumyl)ethyl phosphate

(2-Tetradecanoyloxy-3-tridecanoyloxypropyl) 2-(trimethylazaniumyl)ethyl phosphate

C35H70NO8P (663.483879)


   

[(2R)-1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-decanoyloxypropan-2-yl] icosanoate

[(2R)-1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-decanoyloxypropan-2-yl] icosanoate

C35H70NO8P (663.483879)


   

[1-[2-Aminoethoxy(hydroxy)phosphoryl]oxy-3-propanoyloxypropan-2-yl] heptacosanoate

[1-[2-Aminoethoxy(hydroxy)phosphoryl]oxy-3-propanoyloxypropan-2-yl] heptacosanoate

C35H70NO8P (663.483879)


   

[1-[2-Aminoethoxy(hydroxy)phosphoryl]oxy-3-butanoyloxypropan-2-yl] hexacosanoate

[1-[2-Aminoethoxy(hydroxy)phosphoryl]oxy-3-butanoyloxypropan-2-yl] hexacosanoate

C35H70NO8P (663.483879)


   

(3-Butanoyloxy-2-tricosanoyloxypropyl) 2-(trimethylazaniumyl)ethyl phosphate

(3-Butanoyloxy-2-tricosanoyloxypropyl) 2-(trimethylazaniumyl)ethyl phosphate

C35H70NO8P (663.483879)


   

[1-[2-Aminoethoxy(hydroxy)phosphoryl]oxy-3-hexanoyloxypropan-2-yl] tetracosanoate

[1-[2-Aminoethoxy(hydroxy)phosphoryl]oxy-3-hexanoyloxypropan-2-yl] tetracosanoate

C35H70NO8P (663.483879)


   

(3-Heptanoyloxy-2-icosanoyloxypropyl) 2-(trimethylazaniumyl)ethyl phosphate

(3-Heptanoyloxy-2-icosanoyloxypropyl) 2-(trimethylazaniumyl)ethyl phosphate

C35H70NO8P (663.483879)


   

(2-Docosanoyloxy-3-pentanoyloxypropyl) 2-(trimethylazaniumyl)ethyl phosphate

(2-Docosanoyloxy-3-pentanoyloxypropyl) 2-(trimethylazaniumyl)ethyl phosphate

C35H70NO8P (663.483879)


   

(3-Propanoyloxy-2-tetracosanoyloxypropyl) 2-(trimethylazaniumyl)ethyl phosphate

(3-Propanoyloxy-2-tetracosanoyloxypropyl) 2-(trimethylazaniumyl)ethyl phosphate

C35H70NO8P (663.483879)


   

[1-[2-Aminoethoxy(hydroxy)phosphoryl]oxy-3-pentanoyloxypropan-2-yl] pentacosanoate

[1-[2-Aminoethoxy(hydroxy)phosphoryl]oxy-3-pentanoyloxypropan-2-yl] pentacosanoate

C35H70NO8P (663.483879)


   

[1-[2-Aminoethoxy(hydroxy)phosphoryl]oxy-3-octanoyloxypropan-2-yl] docosanoate

[1-[2-Aminoethoxy(hydroxy)phosphoryl]oxy-3-octanoyloxypropan-2-yl] docosanoate

C35H70NO8P (663.483879)


   

[1-[2-Aminoethoxy(hydroxy)phosphoryl]oxy-3-heptanoyloxypropan-2-yl] tricosanoate

[1-[2-Aminoethoxy(hydroxy)phosphoryl]oxy-3-heptanoyloxypropan-2-yl] tricosanoate

C35H70NO8P (663.483879)


   

(2-Nonadecanoyloxy-3-octanoyloxypropyl) 2-(trimethylazaniumyl)ethyl phosphate

(2-Nonadecanoyloxy-3-octanoyloxypropyl) 2-(trimethylazaniumyl)ethyl phosphate

C35H70NO8P (663.483879)


   

(2-Henicosanoyloxy-3-hexanoyloxypropyl) 2-(trimethylazaniumyl)ethyl phosphate

(2-Henicosanoyloxy-3-hexanoyloxypropyl) 2-(trimethylazaniumyl)ethyl phosphate

C35H70NO8P (663.483879)


   

(3-Acetyloxy-2-pentacosanoyloxypropyl) 2-(trimethylazaniumyl)ethyl phosphate

(3-Acetyloxy-2-pentacosanoyloxypropyl) 2-(trimethylazaniumyl)ethyl phosphate

C35H70NO8P (663.483879)


   

(3-Nonanoyloxy-2-octadecanoyloxypropyl) 2-(trimethylazaniumyl)ethyl phosphate

(3-Nonanoyloxy-2-octadecanoyloxypropyl) 2-(trimethylazaniumyl)ethyl phosphate

C35H70NO8P (663.483879)


   

[(2S)-3-[2-aminoethoxy(hydroxy)phosphoryl]oxy-2-tridecanoyloxypropyl] heptadecanoate

[(2S)-3-[2-aminoethoxy(hydroxy)phosphoryl]oxy-2-tridecanoyloxypropyl] heptadecanoate

C35H70NO8P (663.483879)


   

[(2S)-3-[2-aminoethoxy(hydroxy)phosphoryl]oxy-2-decanoyloxypropyl] icosanoate

[(2S)-3-[2-aminoethoxy(hydroxy)phosphoryl]oxy-2-decanoyloxypropyl] icosanoate

C35H70NO8P (663.483879)


   

[(2S)-2-decanoyloxy-3-heptadecanoyloxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

[(2S)-2-decanoyloxy-3-heptadecanoyloxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C35H70NO8P (663.483879)


   

[(2R)-3-[2-aminoethoxy(hydroxy)phosphoryl]oxy-2-undecanoyloxypropyl] nonadecanoate

[(2R)-3-[2-aminoethoxy(hydroxy)phosphoryl]oxy-2-undecanoyloxypropyl] nonadecanoate

C35H70NO8P (663.483879)


   

[(2R)-1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-undecanoyloxypropan-2-yl] nonadecanoate

[(2R)-1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-undecanoyloxypropan-2-yl] nonadecanoate

C35H70NO8P (663.483879)


   

[(2R)-3-decanoyloxy-2-heptadecanoyloxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

[(2R)-3-decanoyloxy-2-heptadecanoyloxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C35H70NO8P (663.483879)


   

[(2S)-3-hexadecanoyloxy-2-undecanoyloxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

[(2S)-3-hexadecanoyloxy-2-undecanoyloxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C35H70NO8P (663.483879)


   

[(2S)-3-[2-aminoethoxy(hydroxy)phosphoryl]oxy-2-dodecanoyloxypropyl] octadecanoate

[(2S)-3-[2-aminoethoxy(hydroxy)phosphoryl]oxy-2-dodecanoyloxypropyl] octadecanoate

C35H70NO8P (663.483879)


   

1,2-dipentadecanoyl-sn-glycero-3-phosphoethanolamine

1,2-dipentadecanoyl-sn-glycero-3-phosphoethanolamine

C35H70NO8P (663.483879)


   

Hexadecanoic acid, 1-[[[(2-aminoethoxy)hydroxyphosphinyl]oxy]methyl]-2-[(1-oxotetradecyl)oxy]ethyl ester (9CI)

Hexadecanoic acid, 1-[[[(2-aminoethoxy)hydroxyphosphinyl]oxy]methyl]-2-[(1-oxotetradecyl)oxy]ethyl ester (9CI)

C35H70NO8P (663.483879)


   

Hexadecanoic acid, 3-[[(2-aminoethoxy)hydroxyphosphinyl]oxy]-2-[(1-oxotetradecyl)oxy]propyl ester (9CI)

Hexadecanoic acid, 3-[[(2-aminoethoxy)hydroxyphosphinyl]oxy]-2-[(1-oxotetradecyl)oxy]propyl ester (9CI)

C35H70NO8P (663.483879)


   

phosphatidylethanolamine 30:0

phosphatidylethanolamine 30:0

C35H70NO8P (663.483879)


A 1,2-diacyl-sn-glycero-3-phosphoethanolamine zwitterion in which the acyl groups at C-1 and C-2 contain 30 carbons in total with 0 double bonds.

   

MePC(26:0)

MePC(16:0_10:0)

C35H70NO8P (663.483879)


Provides by LipidSearch Vendor. © Copyright 2006-2024 Thermo Fisher Scientific Inc. All rights reserved